As the pandemic subsides, AI has emerged as the next significant force impacting the healthcare industry. Kaohsiung Municipal Hsiao-Kang Hospital is partnering with three companies to develop a comprehensive medical diagnostic support system that integrates AI imaging with physiological data. The hospital will lead the clinical development and on-site validation, while Onyx Healthcare will focus on the integration of AI-based smart medical support systems. SpectroChip will concentrate on developing a spectral chip detection system and building a smart medical big data platform. The overall promotion and marketing activities will be coordinated by Global Life Sciences (GLS).
On August 29, Kaohsiung Municipal Hsiao-Kang Hospital signed a partnership agreement with Onyx Healthcare, Global Life Sciences, and SpectroChip. Dr. Chih-Hsing Hung, Director of the hospital, stated that in recent years, the hospital has invested significant resources in creating a smart hospital. This collaboration with industry partners aims to develop a smart system that integrates both imaging and physiological data. By leveraging AI, the system will provide practical support for clinical operations, helping to reduce resource consumption in medical consultations, accelerate the training of new healthcare professionals, and offer more convenient and reliable medical services to the public.
John Chuang, Global General Manager of Onyx Healthcare, emphasized that this collaboration aligns with their strategy for diversified growth in AI healthcare. By incorporating physiological data collection, they aim to develop a more comprehensive medical support system. For example, AI assistance can help doctors prioritize urgent cases among the numerous test results they review daily. Cheng-Hao Ko, founder of SpectroChip, noted that their series of miniature spectrometers equipped with spectral chips can deliver lab-accurate test results quickly, conveniently, and locally.
Wei Mu-Chung, spokesperson for GLS, which is responsible for global marketing, pointed out that the global AI smart healthcare market is estimated to exceed $500 billion. Accurate diagnostic testing is the starting point of medical care, and by leveraging AI-driven interpretive models, doctors can make more effective medical decisions. He expressed confidence that an integrated platform system can provide global support for telemedicine and precision medicine.
Resource (mandarin): 高雄小港醫結合AI影像與光譜晶片 開發全方位智慧醫療平台
